Literature DB >> 35369655

Novel Clinical Therapies and Technologies in Dialysis Vascular Access.

Edwin A Takahashi1, Sreenivasulu Kilari1, Sanjay Misra1.   

Abstract

The hemodialysis population continues to grow. Although procedures for dialysis have existed for >60 years, significant challenges with vascular access to support hemodialysis persist. Failure of arteriovenous fistulas (AVFs) to mature, loss of AVF and graft patency, thrombosis, and infection hinder long-term access, and add extra health care costs and patient morbidity. There have been numerous innovations over the last decade aimed at addressing the issues. In this study, we review the literature and summarize the recent evolution of drug delivery, graft development, minimally invasive AVF creation, and stem-cell therapy for hemodialysis access.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  arteriovenous fistula; chronic kidney disease; dialysis; drug delivery; stenosis

Mesh:

Year:  2021        PMID: 35369655      PMCID: PMC8676382          DOI: 10.34067/KID.0002962021

Source DB:  PubMed          Journal:  Kidney360        ISSN: 2641-7650


  48 in total

1.  Place of Percutaneous Fistula Devices in Contemporary Management of Vascular Access.

Authors:  Haimanot Wasse
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-01       Impact factor: 8.237

2.  Unanticipated late maturation of an arteriovenous fistula after creation of separate graft access.

Authors:  Hanzhou Li; Serena Jen; Tarun Ramayya; H Gregory Bowers; Eran Rotem
Journal:  Quant Imaging Med Surg       Date:  2018-05

Review 3.  Innovations in vascular access for hemodialysis.

Authors:  Anil K Agarwal; Nabil J Haddad; Tushar J Vachharajani; Arif Asif
Journal:  Kidney Int       Date:  2019-03-04       Impact factor: 10.612

4.  Midterm results of percutaneous arteriovenous fistula creation with the Ellipsys Vascular Access System, technical recommendations, and an algorithm for maintenance.

Authors:  Alexandros Mallios; Pierre Bourquelot; Gilbert Franco; Hadia Hebibi; Hortence Fonkoua; Mahmoud Allouache; Alessandro Costanzo; Romain de Blic; Ghazi Harika; Benoit Boura; William C Jennings
Journal:  J Vasc Surg       Date:  2020-04-08       Impact factor: 4.268

5.  Increased mortality with paclitaxel-eluting stents is driven by lesion length.

Authors:  Asma Mathlouthi; Kevin S Yei; Isaac Naazie; Daniel J Bertges; Mahmoud B Malas
Journal:  J Vasc Surg       Date:  2020-06-29       Impact factor: 4.268

6.  Drug Coated Balloon Angioplasty in Failing AV Fistulas: A Randomized Controlled Trial.

Authors:  Scott O Trerotola; Jeffrey Lawson; Prabir Roy-Chaudhury; Theodore F Saad
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-24       Impact factor: 8.237

7.  Timing of cannulation of arteriovenous grafts: are we too cautious?

Authors:  Julien Al Shakarchi; Nicholas Inston
Journal:  Clin Kidney J       Date:  2015-01-20

8.  Two-year cumulative patency of endovascular arteriovenous fistula.

Authors:  Gerald A Beathard; Terry Litchfield; William C Jennings
Journal:  J Vasc Access       Date:  2019-09-28       Impact factor: 2.283

9.  Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Konstantinos Katsanos; Stavros Spiliopoulos; Panagiotis Kitrou; Miltiadis Krokidis; Dimitrios Karnabatidis
Journal:  J Am Heart Assoc       Date:  2018-12-18       Impact factor: 5.501

10.  Adventitial delivery of nanoparticles encapsulated with 1α, 25-dihydroxyvitamin D3 attenuates restenosis in a murine angioplasty model.

Authors:  Chuanqi Cai; Sreenivasulu Kilari; Chenglei Zhao; Avishek K Singh; Michael L Simeon; Avanish Misra; Yiqing Li; Edwin Takahashi; Rajiv Kumar; Sanjay Misra
Journal:  Sci Rep       Date:  2021-02-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.